Last reviewed · How we verify
Treatment by clopidogrel
Treatment by clopidogrel is a Small molecule drug developed by University Hospital, Bordeaux. It is currently in Phase 1 development.
At a glance
| Generic name | Treatment by clopidogrel |
|---|---|
| Sponsor | University Hospital, Bordeaux |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Epistaxis
- Dyspnoea
- Haematoma
- Haematuria
- Gingival Bleeding
- Hypertension
- Oedema Peripheral
- Angina Pectoris
- Contusion
- Diarrhoea
- Dizziness
- Ecchymosis
Key clinical trials
- PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years (PHASE3)
- Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) (PHASE3)
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant (PHASE4)
- Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial (PHASE3)
- Efficacy and Safety of Tirofiban for Patients With BAD (BRANT) (PHASE3)
- ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion (PHASE4)
- Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE) (PHASE3)
- Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Treatment by clopidogrel CI brief — competitive landscape report
- Treatment by clopidogrel updates RSS · CI watch RSS
- University Hospital, Bordeaux portfolio CI
Frequently asked questions about Treatment by clopidogrel
What is Treatment by clopidogrel?
Treatment by clopidogrel is a Small molecule drug developed by University Hospital, Bordeaux.
Who makes Treatment by clopidogrel?
Treatment by clopidogrel is developed by University Hospital, Bordeaux (see full University Hospital, Bordeaux pipeline at /company/university-hospital-bordeaux).
What development phase is Treatment by clopidogrel in?
Treatment by clopidogrel is in Phase 1.
What are the side effects of Treatment by clopidogrel?
Common side effects of Treatment by clopidogrel include Epistaxis, Dyspnoea, Haematoma, Haematuria, Gingival Bleeding, Hypertension.
Related
- Manufacturer: University Hospital, Bordeaux — full pipeline
- Compare: Treatment by clopidogrel vs similar drugs
- Pricing: Treatment by clopidogrel cost, discount & access